NeuroHealing Pharmaceuticals Presents Clinical Data for NH001 in Coma Recovery at The American Society for Experimental NeuroTherapeutics (ASENT) Annual Meeting
Newton, Mass., March 12, 2007 NeuroHealing Pharmaceuticals Inc., a a clinical stage private company developing products for individuals with chronic brain injuries, today announced that it had presented new clinical data for its coma recovery compound, NH001, at the American Society for Experimental NeuroTherapeutics (ASENT) 9th annual meeting, held in Washington, DC from March 7-10,…